Alpine Associates Management’s Genomic Health, Inc. GHDX Stock Holding History

Alpine Associates Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-789,540	Closed	-$53.5M	–	63
2019 Q3	$53.5M	Buy	+789,540	New	+$54.2M	1.75%	22

Alpine Associates Management's GHDX Position: Q4 2019 in Review

Alpine Associates Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 789,540 shares — an estimated $53.5M sold.

Alpine Associates Management first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $53.5M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Alpine Associates Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Alpine Associates Management sold 789,540 Genomic Health, Inc. shares in Q4 2019, an estimated $53.5M.
Alpine Associates Management first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
Alpine Associates Management's Genomic Health, Inc. position peaked at $53.5M in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Alpine Associates Management's 13F filing for Q4 2019, filed 13 Feb 2020.